The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Chemoradiation (CRT) followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant CRT and surgery for locally advanced rectal cancer: Results of the Spanish GCR-3 randomized phase II trial after a median follow-up of 5 years.
Carlos Fernandez-Martos
No relevant relationships to disclose
Carles Pericay
No relevant relationships to disclose
Jorge Aparicio
No relevant relationships to disclose
Maria Jose Safont
No relevant relationships to disclose
Antonia Salud
No relevant relationships to disclose
Bartomeu Massuti
No relevant relationships to disclose
Vicente Alonso
No relevant relationships to disclose
Ruth Vera
No relevant relationships to disclose
Pilar Escudero
No relevant relationships to disclose
Marta Martin-Richard
No relevant relationships to disclose
Carlos Bosch
No relevant relationships to disclose
Juan Maurel
No relevant relationships to disclose